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Objectives
Data safe havens can bring together and combine a rich ar-
ray of anonymised person-based data for research and policy
evaluation within a secure setting. To date, the majority of
available datasets have been structured micro-data derived from
routine health-related records. Possibilities are opening up for
the greater reuse of genomic data such as Genome Wide Asso-
ciation studies (GWAS) and Whole Exome/Genome Sequencing
(WES or WGS). However, there are considerable challenges to
be addressed if the benefits of using these data in combination
with health-related data are to be realized safely.
Approach
We explore the benefits and challenges of using genomic datasets
with health-related data, and using the Secure Anonymised In-
formation Linkage (SAIL) system as a case study, the impli-
cations and way forward for Data Safe Havens in seeking to
incorporate genomic data for use with health-related data.
Results
The benefits of using GWAS, WES and WGS data in conjunction
with health-related data include the potential to explore genetics
at a population level and open up novel research areas. These
include the ability to increasingly stratify and personalize how
medical indications are detected and treated through precision
medicine by understanding rare conditions and adding socioeco-
nomic and environmental context to genomic data. Among the
challenges are: data availability, computing capacity, technical
solutions, legal and regulatory frameworks, public perceptions,
individual privacy and organizational risk. Many of the chal-
lenges within these areas are common to person-based data in
general, and often Data Safe Havens have been designed to ad-
dress these. But there are also aspects of these challenges, and
other challenges, specific to genomic data. These include issues
due to the unknown clinical significance of genomic information
now or in the future, with corresponding risks for privacy and
impact on individuals.
Conclusion
Genomic data sets contain vast amounts of valuable informa-
tion, some of which is currently undefined, but which may have
direct bearing on individual health at some point. The use of
these data in combination with health-related data has the po-
tential to bring great benefits, better clinical trial stratification,
epidemiology project design and clinical improvements. It is,
therefore, essential that such data are surrounded by a properly-
designed, robust governance framework including technical and
procedural access controls that enable the data to be used safely.
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